[go: up one dir, main page]

PE20000478A1 - Derivados de higromicina a - Google Patents

Derivados de higromicina a

Info

Publication number
PE20000478A1
PE20000478A1 PE1999000362A PE00036299A PE20000478A1 PE 20000478 A1 PE20000478 A1 PE 20000478A1 PE 1999000362 A PE1999000362 A PE 1999000362A PE 00036299 A PE00036299 A PE 00036299A PE 20000478 A1 PE20000478 A1 PE 20000478A1
Authority
PE
Peru
Prior art keywords
alkyl
cycloalkyl
methyl
refers
hygromycin
Prior art date
Application number
PE1999000362A
Other languages
English (en)
Inventor
Ii Robert Gerald Linde
Katherine Elizabeth Brighty
Ellen Lester Mccormick
Martin Raymond Jefson
Subramanian Sam Guhan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20000478A1 publication Critical patent/PE20000478A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R1 ES H; R2 ES -NR3R4, -NR4COR3, -OCONR3R4, -OR3; R1 Y R2 FORMAN =N-OR3, =CR4R3, =CR4ROR3, ENTRE OTROS; R3 ES H, ALQUILO C1-10, ALQUENILO C2-C10, -(CH2)t(CICLOALQUILO C3-C10), -(CH2)t(ARILO C6-10), -(CH2)t(HETEROCICLO DE 4-10 MIEMBROS); t ES 0-5; CUANDO R3 NO ES H, METILO, ETILO; R1 ES H; R2 ES OR3; R3 SE CONDENSA OPCIONALMENTE CON UN ANILLO DE BENCENO, UN GRUPO CICLICO SATURADO C5-C8, UN GRUPO HETEROCICLICO DE 4-10 MIEMBROS OPCIONALMENTE SUSTITUIDOS CON R5; R4 ES H, ALQUILO C1-C10; R5 ES ALQUILO C1-C10, CICLOALQUILO C3-C10, HALO, CIANO, -OR6, -NR7COOR9, ENTRE OTROS. R6 ES H, ALQUILO C1-C10, CICLOALQUILO C3-C10, -(CH2)m(ARILO C6-C10); m ES 0-4. R7 ES H, ALQUILO C1-C6; R9 ES R6 EXCEPTO H. UN COMPUESTO PREFERIDO ES (Z)-O-[(3-FLUOROFENIL)METIL]OXIMA DE 5-DESOXI-5-[[3-[4-[(6-DESOXI-ß-D-ARABINO-HEXOFURANOS-5-ULOS-1-IL)OXI]-3-HIDROXIFENIL]-2-METIL-1-OXO-2-(E)-PROPENIL]AMINO]-1,2-O-METILEN-D-NEO-INOSITOL, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE HIGROMICINA A Y EPI-HIGROMICINA EN UNA RELACION DE 10:1. EL COMPUESTO I PUEDE SER UTIL PARA EL TRATAMIENTO DE UNA INFECCION POR BACTERIAS, POR PROTOZOOS
PE1999000362A 1998-05-04 1999-05-03 Derivados de higromicina a PE20000478A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8404298P 1998-05-04 1998-05-04

Publications (1)

Publication Number Publication Date
PE20000478A1 true PE20000478A1 (es) 2000-05-31

Family

ID=22182520

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000362A PE20000478A1 (es) 1998-05-04 1999-05-03 Derivados de higromicina a

Country Status (37)

Country Link
US (1) US6313100B1 (es)
EP (1) EP1075483B1 (es)
JP (1) JP2002513796A (es)
KR (1) KR100402560B1 (es)
CN (1) CN1299365A (es)
AP (3) AP0102296A0 (es)
AR (1) AR016251A1 (es)
AT (2) ATE255588T1 (es)
AU (1) AU755806B2 (es)
BG (1) BG105008A (es)
BR (1) BR9910206A (es)
CA (1) CA2331297C (es)
DE (2) DE69929723D1 (es)
DK (1) DK1075483T3 (es)
DZ (1) DZ2780A1 (es)
EA (2) EA200200779A1 (es)
ES (1) ES2209419T3 (es)
GT (1) GT199900064A (es)
HR (1) HRP20000747A2 (es)
HU (1) HUP0102066A3 (es)
ID (1) ID27030A (es)
IL (1) IL139165A0 (es)
IS (1) IS5681A (es)
MA (1) MA24852A1 (es)
NO (1) NO20005552L (es)
NZ (1) NZ507452A (es)
OA (1) OA11508A (es)
PA (1) PA8471801A1 (es)
PE (1) PE20000478A1 (es)
PL (1) PL344521A1 (es)
PT (1) PT1075483E (es)
SK (1) SK16452000A3 (es)
TN (1) TNSN99083A1 (es)
TR (1) TR200003250T2 (es)
WO (1) WO1999057125A2 (es)
YU (1) YU66900A (es)
ZA (1) ZA993064B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1135400A1 (en) 1998-12-02 2001-09-26 Pfizer Products Inc. Hygromycin a derivatives as antibacterial agents
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6771019B1 (en) * 1999-05-14 2004-08-03 Ifire Technology, Inc. Electroluminescent laminate with patterned phosphor structure and thick film dielectric with improved dielectric properties
OA12277A (en) * 2000-06-02 2006-05-11 Pfizer Prod Inc Hygromycin A derivatives for the treatment of bacterial and protozoal infections.
CN102168034B (zh) * 2010-11-29 2012-12-05 中国科学院南海海洋研究所 一种海洋链霉菌以及利用该菌制备替达霉素a和b的方法
JP2016069333A (ja) * 2014-09-30 2016-05-09 公益財団法人微生物化学研究会 新規化合物、その製造方法、及びその用途、並びに、新規微生物
CN104480039B (zh) * 2014-11-25 2017-09-12 辽宁大学 抗生素产生菌及其应用
CA3110075A1 (en) 2018-08-20 2020-02-27 Northeastern University Hygromycin a compounds and methods of treating spirochete diseases
KR102756165B1 (ko) * 2019-07-16 2025-01-20 재단법인 한국파스퇴르연구소 항―메티실린 내성 황색포도상구균 화합물 및 이의 의약 용도
TWI771766B (zh) 2019-10-04 2022-07-21 美商輝瑞股份有限公司 二醯基甘油醯基轉移酶2 抑制劑
JP2022058085A (ja) 2020-02-24 2022-04-11 ファイザー・インク ジアシルグリセロールアシルトランスフェラーゼ2阻害剤とアセチル-CoAカルボキシラーゼ阻害剤との組合せ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0213692B1 (en) 1985-06-27 1990-09-26 Takeda Chemical Industries, Ltd. Use of hygromycin and epihygromycin in the treatment of swine dysentery
GB8605245D0 (en) 1986-03-04 1986-04-09 Fujisawa Pharmaceutical Co Prophylactic & therapeutic agent

Also Published As

Publication number Publication date
EA003305B1 (ru) 2003-04-24
KR20010043303A (ko) 2001-05-25
ZA993064B (en) 2000-12-06
DZ2780A1 (fr) 2005-04-23
PL344521A1 (en) 2001-11-05
EA200200779A1 (ru) 2002-12-26
ES2209419T3 (es) 2004-06-16
NZ507452A (en) 2003-04-29
ATE255588T1 (de) 2003-12-15
CA2331297A1 (en) 1999-11-11
ID27030A (id) 2001-02-22
EP1075483A2 (en) 2001-02-14
YU66900A (sh) 2003-12-31
AU3341999A (en) 1999-11-23
AP0102296A0 (en) 2000-11-04
JP2002513796A (ja) 2002-05-14
IL139165A0 (en) 2001-11-25
WO1999057125A2 (en) 1999-11-11
PA8471801A1 (es) 2000-09-29
BR9910206A (pt) 2001-01-30
AR016251A1 (es) 2001-06-20
GT199900064A (es) 2000-10-24
AU755806B2 (en) 2002-12-19
AP1266A (en) 2004-03-29
WO1999057125A3 (en) 1999-12-29
EP1075483B1 (en) 2003-12-03
TNSN99083A1 (fr) 2005-11-10
EA200001029A1 (ru) 2001-04-23
CN1299365A (zh) 2001-06-13
DE69913333D1 (de) 2004-01-15
HRP20000747A2 (en) 2001-06-30
CA2331297C (en) 2004-12-28
PT1075483E (pt) 2004-03-31
KR100402560B1 (ko) 2003-10-17
OA11508A (en) 2004-02-09
MA24852A1 (fr) 1999-12-31
ATE317448T1 (de) 2006-02-15
NO20005552D0 (no) 2000-11-03
NO20005552L (no) 2001-01-02
BG105008A (en) 2001-09-28
IS5681A (is) 2000-10-24
HUP0102066A2 (hu) 2001-11-28
HUP0102066A3 (en) 2003-07-28
US6313100B1 (en) 2001-11-06
DK1075483T3 (da) 2004-03-15
SK16452000A3 (sk) 2001-09-11
DE69913333T2 (de) 2004-10-07
TR200003250T2 (tr) 2001-01-22
AP2001002296A0 (en) 2001-12-31
AP9901527A0 (en) 1999-06-30
DE69929723D1 (de) 2006-04-20

Similar Documents

Publication Publication Date Title
PE20000478A1 (es) Derivados de higromicina a
ATE139783T1 (de) Azasteroide zur behandlung prostatischer hypertrophie, ihre herstellung und verwendung
ES2100878T3 (es) Material organico estabilizado.
DK0595851T3 (da) Fremgangsmåde til fremstilling af sertralin-mellemprodukter
PE20010613A1 (es) Antagonistas de la hormona concentradora de la melanina
PE107999A1 (es) Derivados 3-amidinoanilina, inhibidores del factor x de coagulacion de la sangre activado e intermediarios de los mismos
ES2096933T3 (es) Compuesto capaz de permanecer en la region intracerebral y utilizacion del mismo.
KR950005917A (ko) 벤조디푸라논 화합물을 함유하는 조성물 및 그를 이용한 소수성 재료의 착색방법
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
PE79599A1 (es) Derivados de 5'-desoxicitidina
AR005916A1 (es) Compuestos de oxadiazol, y de tiadiazol, su uso, procedimientos para prepararlos, composiciones farmaceuticas que los contienen y un compuesto util como intermedio
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
DE69204840D1 (de) Verfahren zur Herstellung von Sertralin.
PE20001241A1 (es) Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
AU561772B2 (en) Cyclobutyl methylamine derivatives
DE60022416D1 (de) Verfahren zur Herstellung von 2-Alkyl-3-aminothiophen Derivate und 3-Aminothiophen Derivate
KR950032158A (ko) 신규의 티아진 또는 티오모폴린 유도체
KR920701205A (ko) 에르골린 유도체의 제조방법
PE86698A1 (es) Derivados de indolina
PE20000474A1 (es) Inhibidores de la oxido nitrico sintasa
PE20000440A1 (es) Derivados de 2"-desoxi higromicina
ES2054829T3 (es) Antibioticos del grupo mureidomicina, su preparacion y su empleo.
JPS5657742A (en) N*n**dialkylaminoalkylethylenediamine and its manufacture
AU6797590A (en) Improvements in or relating to organic compounds
AR011066A1 (es) Procesos para la sintesis de alfa gal(1-4) beta gal (1-4)glc-or.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed